Tapewire

Nasdaq · USD

CTMX

CytomX Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5124
SEC CIK
0001501989
Parsed reports
342

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202600
Mar 202604
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 05, 2018 Filed Jan 9, 2018 16:20 UTC
McCarthy Sean A.Director · President and CEO
SaleCommon Stock 6,526 $25.01 $163,215.26
Disclosure

SEC source: 0001140361-18-001360 · doc1.xml · nonDerivative · entry 2

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,643

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.17, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
January 05, 2018 Filed Jan 9, 2018 16:20 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 6,526 $1.13 $7,399.83
Disclosure

SEC source: 0001140361-18-001360 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,169

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2018 Filed Jan 3, 2018 20:23 UTC
RAY DEBANJANChief Financial Officer
SaleCommon Stock 2,500 $21.11 $52,775.00
Disclosure

SEC source: 0001140361-18-000410 · doc1.xml · nonDerivative · entry 1

RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,289

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

Read SEC document
January 02, 2018 Filed Jan 4, 2018 17:25 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 13,052 $0.00 Strike: $1.13 $0.00
Disclosure

SEC source: 0001140361-18-000712 · doc1.xml · derivative · entry 4

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343,669

Underlying: Common Stock · 13,052 shares

Expires 2021-09-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
January 02, 2018 Filed Jan 4, 2018 17:25 UTC
McCarthy Sean A.Director · President and CEO
SaleCommon Stock 13,052 $21.04 $274,614.08
Disclosure

SEC source: 0001140361-18-000712 · doc1.xml · nonDerivative · entry 2

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,643

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.69 to $21.49, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
January 02, 2018 Filed Jan 4, 2018 17:25 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 13,052 $1.13 $14,799.66
Disclosure

SEC source: 0001140361-18-000712 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 26, 2017 Filed Dec 28, 2017 17:56 UTC SaleCommon Stock 5,000 $22.29 $111,425.50
Disclosure

SEC source: 0001140361-17-047635 · doc1.xml · nonDerivative · entry 1

GLUCK FREDERICK W · CIK 0001184126 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Frederick W. Gluck 1997 Family Trust dtd July 28, 1997

Disclosed balance after: 306,643

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.03 to $22.53, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is a trustee of Frederick W. Gluck 1997 Family Trust dtd July 28, 1997.

Read SEC document
December 15, 2017 Filed Dec 19, 2017 17:23 UTC
HUMPHREY RACHELChief Medical Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 15,117 $0.00 Strike: $6.61 $0.00
Disclosure

SEC source: 0001140361-17-046649 · doc1.xml · derivative · entry 2

HUMPHREY RACHEL · CIK 0001579781 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262,980

Underlying: Common Stock · 15,117 shares

Expires 2025-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option vests 25% on August 28, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month, except the final installment, which shall vest on August 28, 2019.

Read SEC document
December 15, 2017 Filed Dec 19, 2017 17:23 UTC
HUMPHREY RACHELChief Medical Officer
Exercise / conversionCommon Stock 15,117 $6.61 $99,994.42
Disclosure

SEC source: 0001140361-17-046649 · doc1.xml · nonDerivative · entry 1

HUMPHREY RACHEL · CIK 0001579781 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,234

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 08, 2017 Filed Dec 12, 2017 19:35 UTC
Kavanaugh William MichaelCSO, Head Res.&Non-Clin. Dev.
Exercise / conversionStock Option (Right to Buy) · Derivative 5,130 $0.00 Strike: $1.57 $0.00
Disclosure

SEC source: 0001140361-17-045842 · doc1.xml · derivative · entry 2

Kavanaugh William Michael · CIK 0001578767 · CSO, Head Res.&Non-Clin. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,912

Underlying: Common Stock · 5,130 shares

Expires 2025-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option vests 25% on January 9, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month.

Read SEC document
December 08, 2017 Filed Dec 12, 2017 19:35 UTC
Kavanaugh William MichaelCSO, Head Res.&Non-Clin. Dev.
Exercise / conversionCommon Stock 5,130 $1.57 $8,079.24
Disclosure

SEC source: 0001140361-17-045842 · doc1.xml · nonDerivative · entry 1

Kavanaugh William Michael · CIK 0001578767 · CSO, Head Res.&Non-Clin. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,047

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2017 Filed Dec 5, 2017 17:56 UTC
RAY DEBANJANChief Financial Officer
SaleCommon Stock 2,500 $20.58 $51,450.00
Disclosure

SEC source: 0001140361-17-045018 · doc1.xml · nonDerivative · entry 2

RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,789

F2 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

Read SEC document
December 01, 2017 Filed Dec 5, 2017 17:55 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 10,240 $0.00 Strike: $1.13 $0.00
Disclosure

SEC source: 0001140361-17-045017 · doc1.xml · derivative · entry 7

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 356,721

Underlying: Common Stock · 10,240 shares

Expires 2021-09-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
December 01, 2017 Filed Dec 5, 2017 17:55 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 4,100 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001140361-17-045017 · doc1.xml · derivative · entry 6

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,193

Underlying: Common Stock · 4,100 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
December 01, 2017 Filed Dec 5, 2017 17:55 UTC
McCarthy Sean A.Director · President and CEO
SaleCommon Stock 14,340 $20.60 $295,404.00
Disclosure

SEC source: 0001140361-17-045017 · doc1.xml · nonDerivative · entry 4

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,643

F2 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.42 to $20.78, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
December 01, 2017 Filed Dec 5, 2017 17:55 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 10,240 $1.13 $11,611.14
Disclosure

SEC source: 0001140361-17-045017 · doc1.xml · nonDerivative · entry 3

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,983

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2017 Filed Dec 5, 2017 17:55 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 4,100 $0.95 $3,874.50
Disclosure

SEC source: 0001140361-17-045017 · doc1.xml · nonDerivative · entry 2

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,743

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 30, 2017 Filed Dec 5, 2017 17:56 UTC
RAY DEBANJANChief Financial Officer
GrantCommon Stock 163 $12.15 $1,979.88
Disclosure

SEC source: 0001140361-17-045018 · doc1.xml · nonDerivative · entry 1

RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,289

F1 · kind: 163 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
November 30, 2017 Filed Dec 5, 2017 17:55 UTC
McCarthy Sean A.Director · President and CEO
GrantCommon Stock 398 $12.15 $4,834.31
Disclosure

SEC source: 0001140361-17-045017 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,643

F1 · kind: 398 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
November 01, 2017 Filed Nov 3, 2017 20:34 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 14,342 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001140361-17-040976 · doc1.xml · derivative · entry 4

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,293

Underlying: Common Stock · 14,342 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
November 01, 2017 Filed Nov 3, 2017 20:34 UTC
McCarthy Sean A.Director · President and CEO
SaleCommon Stock 14,342 $19.86 $284,832.12
Disclosure

SEC source: 0001140361-17-040976 · doc1.xml · nonDerivative · entry 2

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,245

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.61 to $20.22, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
November 01, 2017 Filed Nov 3, 2017 20:34 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 14,342 $0.95 $13,553.19
Disclosure

SEC source: 0001140361-17-040976 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,587

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 01, 2017 Filed Nov 3, 2017 20:33 UTC
RAY DEBANJANChief Financial Officer
SaleCommon Stock 2,500 $20.00 $50,000.00
Disclosure

SEC source: 0001140361-17-040975 · doc1.xml · nonDerivative · entry 1

RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,126

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

Read SEC document
October 23, 2017 Filed Oct 24, 2017 19:26 UTC GrantStock Option (right to buy) · Derivative 28,000 $0.00 Strike: $20.04 $0.00
Disclosure

SEC source: 0001140361-17-039390 · doc1.xml · derivative · entry 1

Fuchs Charles S. · CIK 0001719576 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,000

Underlying: Common Stock · 28,000 shares

Expires 2027-10-22

F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from October 23, 2017 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
October 18, 2017 Filed Oct 19, 2017 16:00 UTC
TRV GP, LLC10% owner
Levin Mark J10% owner
STARR KEVIN P10% owner
OtherCommon Stock 1,000,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-17-024464 · doc4.xml · nonDerivative · entry 1

THIRD ROCK VENTURES LP · CIK 0001408591 · 10% owner

Third Rock Ventures GP, L.P. · CIK 0001578976 · 10% owner

TRV GP, LLC · CIK 0001578973 · 10% owner

LEVIN MARK J · CIK 0001180428 · 10% owner

STARR KEVIN P · CIK 0001192603 · 10% owner

TEPPER ROBERT I · CIK 0001192595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,320,348

F1 · kind: Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. ("TRV"), TRV distributed on October 18, 2017, for no consideration, 1,000,000 shares of Common Stock of the Issuer (the "Shares") to its limited partners and to Third Rock Ventures GP, L.P. ("TRV GP"), the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.

F1 · price: Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. ("TRV"), TRV distributed on October 18, 2017, for no consideration, 1,000,000 shares of Common Stock of the Issuer (the "Shares") to its limited partners and to Third Rock Ventures GP, L.P. ("TRV GP"), the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.

F2 · ownership.direct: These shares are directly held by TRV. The general partner of TRV is TRV GP. The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC"). The individual managers of TRV GP LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.

Read SEC document
October 04, 2017 Filed Oct 4, 2017 16:09 UTC SaleCommon Stock 24,777 $24.34 $603,072.18
Disclosure

SEC source: 0000899243-17-023514 · doc4.xml · nonDerivative · entry 1

TEPPER ROBERT I · CIK 0001192595 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,516

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Read SEC document
October 04, 2017 Filed Oct 6, 2017 12:18 UTC SaleCommon Stock 10,000 $24.27 $242,680.00
Disclosure

SEC source: 0001140361-17-037760 · doc1.xml · nonDerivative · entry 1

GLUCK FREDERICK W · CIK 0001184126 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Frederick W. Gluck 1997 Family Trust dtd July 28, 1997

Disclosed balance after: 311,643

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.81 to $24.38, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is a trustee of Frederick W. Gluck 1997 Family Trust dtd July 28, 1997.

Read SEC document
October 04, 2017 Filed Oct 6, 2017 22:37 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock · Derivative 19,120 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001140361-17-037828 · doc1.xml · derivative · entry 4

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,635

Underlying: Common Stock · 19,120 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

F5 · balance_after: Previous Form 4s filed by the Reporting Person included an error in the number of securities beneficially owned by the Reporting Person in Table II, Box 9. The number of derivative securities beneficially owned as reported in Table II, Box 9 of this Form 4 has been adjusted to correct the previous errors and reflects the current number of derivative securities beneficially owned as of this filing date.

Read SEC document
October 04, 2017 Filed Oct 6, 2017 22:37 UTC
McCarthy Sean A.Director · President and CEO
SaleCommon Stock 19,120 $24.13 $461,365.60
Disclosure

SEC source: 0001140361-17-037828 · doc1.xml · nonDerivative · entry 2

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,245

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.51 to $24.39, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 04, 2017 Filed Oct 6, 2017 22:37 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 19,120 $0.95 $18,068.40
Disclosure

SEC source: 0001140361-17-037828 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,365

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 04, 2017 Filed Oct 6, 2017 16:20 UTC
Kavanaugh William MichaelCSO, Head Res.&Non-Clin. Dev.
Exercise / conversionStock Option (Right to Buy) · Derivative 48,368 $0.00 Strike: $4.47 $0.00
Disclosure

SEC source: 0001140361-17-037761 · doc1.xml · derivative · entry 3

Kavanaugh William Michael · CIK 0001578767 · CSO, Head Res.&Non-Clin. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,368

Underlying: Common Stock · 48,368 shares

Expires 2025-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
October 04, 2017 Filed Oct 6, 2017 16:20 UTC
Kavanaugh William MichaelCSO, Head Res.&Non-Clin. Dev.
SaleCommon Stock 48,368 $24.34 $1,177,277.12
Disclosure

SEC source: 0001140361-17-037761 · doc1.xml · nonDerivative · entry 2

Kavanaugh William Michael · CIK 0001578767 · CSO, Head Res.&Non-Clin. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,917

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

Read SEC document
October 04, 2017 Filed Oct 6, 2017 16:20 UTC
Kavanaugh William MichaelCSO, Head Res.&Non-Clin. Dev.
Exercise / conversionCommon Stok 48,368 $4.47 $216,340.39
Disclosure

SEC source: 0001140361-17-037761 · doc1.xml · nonDerivative · entry 1

Kavanaugh William Michael · CIK 0001578767 · CSO, Head Res.&Non-Clin. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,285

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 23:56 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 9,562 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001140361-17-037691 · doc1.xml · derivative · entry 4

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,481

Underlying: Common Stock · 9,562 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 23:56 UTC
McCarthy Sean A.Director · President and CEO
SaleCommon Stock 9,562 $18.57 $177,566.34
Disclosure

SEC source: 0001140361-17-037691 · doc1.xml · nonDerivative · entry 2

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,245

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.10 to $18.97, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 23:56 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 9,562 $0.95 $9,036.09
Disclosure

SEC source: 0001140361-17-037691 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,807

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 16:38 UTC
RAY DEBANJANChief Financial Officer
SaleCommon Stock 2,500 $18.10 $45,250.00
Disclosure

SEC source: 0001140361-17-037554 · doc1.xml · nonDerivative · entry 1

RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,626

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

Read SEC document
September 26, 2017 Filed Sep 27, 2017 16:12 UTC SaleCommon Stock 5,000 $17.30 $86,476.00
Disclosure

SEC source: 0001140361-17-036614 · doc1.xml · nonDerivative · entry 1

GLUCK FREDERICK W · CIK 0001184126 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Frederick W. Gluck 1997 Family Trust dtd July 28, 1997

Disclosed balance after: 321,643

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.10 to $17.76, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is a trustee of Frederick W. Gluck 1997 Family Trust dtd July 28, 1997.

Read SEC document
September 19, 2017 Filed Sep 21, 2017 16:00 UTC SaleCommon Stock 20,000 $18.00 $360,000.00
Disclosure

SEC source: 0000899243-17-022406 · doc4.xml · nonDerivative · entry 1

TEPPER ROBERT I · CIK 0001192595 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,293

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Read SEC document
September 07, 2017 Filed Feb 12, 2018 23:00 UTC
McCarthy Sean A.Director · President and CEO
GiftCommon Stock 4,500 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-006690 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 154,237

F1 · ownership.nature: Held in McCarthy Family Trust dated August 9, 2001, Sean A. McCarthy and Jeanette J. McCarthy, Trustees.

Read SEC document
September 01, 2017 Filed Sep 5, 2017 22:18 UTC
RAY DEBANJANChief Financial Officer
SaleCommon Stock 2,500 $17.17 $42,925.00
Disclosure

SEC source: 0001140361-17-034349 · doc1.xml · nonDerivative · entry 1

RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,126

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

Read SEC document
September 01, 2017 Filed Sep 5, 2017 22:17 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 9,930 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001140361-17-034348 · doc1.xml · derivative · entry 4

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,043

Underlying: Common Stock · 9,930 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
September 01, 2017 Filed Sep 5, 2017 22:17 UTC
McCarthy Sean A.Director · President and CEO
SaleCommon Stock 9,930 $17.32 $171,987.60
Disclosure

SEC source: 0001140361-17-034348 · doc1.xml · nonDerivative · entry 2

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,245

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.01 to $17.50, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 01, 2017 Filed Sep 5, 2017 22:17 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 9,930 $0.95 $9,383.85
Disclosure

SEC source: 0001140361-17-034348 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,175

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 01, 2017 Filed Sep 22, 2017 18:59 UTC Amendment
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 9,930 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001140361-17-036202 · doc1.xml · derivative · entry 5

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,043

Underlying: Common Stock · 9,930 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
September 01, 2017 Filed Sep 22, 2017 18:59 UTC Amendment
McCarthy Sean A.Director · President and CEO
SaleCommon Stock 368 $17.50 $6,440.00
Disclosure

SEC source: 0001140361-17-036202 · doc1.xml · nonDerivative · entry 3

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,245

Read SEC document
September 01, 2017 Filed Sep 22, 2017 18:59 UTC Amendment
McCarthy Sean A.Director · President and CEO
SaleCommon Stock 9,562 $17.32 $165,613.84
Disclosure

SEC source: 0001140361-17-036202 · doc1.xml · nonDerivative · entry 2

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,613

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.01 to $17.50, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 01, 2017 Filed Sep 22, 2017 18:59 UTC Amendment
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 9,930 $0.95 $9,383.85
Disclosure

SEC source: 0001140361-17-036202 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,175

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 31, 2017 Filed Sep 1, 2017 20:28 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 18,756 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001140361-17-034164 · doc1.xml · derivative · entry 5

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,973

Underlying: Common Stock · 18,756 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
August 31, 2017 Filed Sep 1, 2017 20:28 UTC
McCarthy Sean A.Director · President and CEO
SaleCommon Stock 3,000 $17.51 $52,530.00
Disclosure

SEC source: 0001140361-17-034164 · doc1.xml · nonDerivative · entry 3

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,245

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.